Recently, a research indicate the hyperacetylation of H3K9 at EGR1 binding sites in promoter region II of the GDNF gene can up-regulate the binding of EGR1 to increase GDNF gene transcription in glioma cells [15]. Here, EGR1 is linked to central nervous system cancer.